Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BCPC
BCPC logo

BCPC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Balchem Corp (BCPC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
168.110
1 Day change
0.66%
52 Week Range
183.900
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

BCPC is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock trend is still constructive, but there is no clear catalyst, no recent positive news, no strong proprietary buy signal, and insider selling offsets the bullish hedge fund activity. Because the user is impatient and wants a direct answer, my view is to wait rather than buy immediately. If forced to choose today, hold is the better call.

Technical Analysis

The technical setup is mildly bullish. MACD histogram is positive at 0.501, but it is contracting, which suggests momentum is not accelerating. RSI_6 at 61.916 is neutral-to-slightly bullish, not overbought. The moving averages are aligned bullishly with SMA_5 > SMA_20 > SMA_200, indicating the broader trend remains upward. Price at 168.99 is very close to pivot at 168.955, with near resistance at 172.632 and support at 165.279. This suggests the stock is range-bound near a decision point rather than offering a clear low-risk entry.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Options sentiment is bullish based on the very low put-call open interest ratio of 0.14, which implies far more calls than puts. However, the option volume today is extremely light, and the current option activity is not strong enough to confirm a powerful near-term breakout. IV is moderate with 30d IV at 27.39, IV percentile at 43.65, and IV rank at 7, so there is no major fear premium embedded.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
8

Positive Catalysts

  • Hedge funds are buying aggressively, with buying amount up 2062.50% over the last quarter. The technical trend remains positive with bullish moving averages. Options positioning is also sentiment-positive given the low put-call open interest ratio. There is no recent negative news flow, which removes an immediate overhang.

Neutral/Negative Catalysts

  • Insiders are selling heavily, with selling amount up 1060.90% over the last month. There was no news in the recent week, so there is no event-driven catalyst to push the stock higher. The AI Stock Picker has no signal today and SwingMax has no recent signal. The price is also sitting near pivot resistance, limiting immediate upside follow-through.

Financial Performance

No usable financial snapshot was provided because the financial data returned an error. As a result, I cannot confirm the latest quarter revenue or earnings trend. Since the latest quarter season is unavailable, there is not enough financial evidence here to strengthen a long-term buy case.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so the recent analyst trend cannot be confirmed. Based on the available information, Wall Street appears mixed-to-neutral: hedge fund buying is a positive, but insider selling, lack of fresh news, and the absence of a proprietary buy signal weaken the bull case. Overall, the pros view is modestly constructive, while the cons view is that the stock lacks a clear near-term catalyst and is not compelling enough for an immediate purchase.

Wall Street analysts forecast BCPC stock price to rise
Analyst Rating
0
Wall Street analysts forecast BCPC stock price to rise
Buy
Hold
Sell
0
Current: 167.010
sliders
Low
0
Averages
0
High
0
0
Current: 167.010
sliders
Low
0
Averages
0
High
0
Rothschild & Co Redburn
Neutral
initiated
$162
AI Analysis
2025-12-05
Reason
Rothschild & Co Redburn
Price Target
$162
AI Analysis
2025-12-05
initiated
Neutral
Reason
Rothschild & Co Redburn initiated coverage of Balchem with a Neutral rating and $162 price target. The company has a "resilient" business model built upon niche high-growth products, the analyst tells investors in a research note. However, the firm finds Balchem's valuation as "rich" at current share levels.
H.C. Wainwright
Buy
maintain
$189 -> $190
2025-10-22
Reason
H.C. Wainwright
Price Target
$189 -> $190
2025-10-22
maintain
Buy
Reason
H.C. Wainwright raised the firm's price target on Balchem to $190 from $189 and keeps a Buy rating on the shares. The firm remains confident in Balchem's long-term prospects following the Q3 beat. The company's sales performance and operational efficiency are driving growth, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BCPC
Unlock Now

People Also Watch